Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus InfectionKimberly Workowski, Susanna Naggie, Hugo E. Vargas et al.|Clinical Infectious Diseases|2018Cited by 726
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical TrialDean Follmann, Lindsey R. Baden, Holly Janes et al.|Annals of Internal Medicine|2022Cited by 138